MD Scientific   Report issue

For profit Phase 3
Founded: Raleigh NC United States (2003)
Status: No NME R&D (2003)

Organization Overview

First Clinical Trial
2010
NCT00930436
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now